BC
TECH icon

Bridgefront Capital’s Bio-Techne TECH Stock Holding History

Bridgefront Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
+15,017
New +$811K 0.28% 110
2024
Q3 		– Sell
-9,558
Closed -$685K – 708
2024
Q2 		$685K Buy
9,558
+3,331
+53% +$245K 0.29% 105
2024
Q1 		$438K Buy
+6,227
New +$446K 0.33% 93
2023
Q4 		– Sell
-3,397
Closed -$231K – 562
2023
Q3 		$231K Buy
3,397
+859
+34% +$67.9K 0.16% 287
2023
Q2 		$207K Buy
+2,538
New +$204K 0.11% 379
2023
Q1 		– Sell
-3,018
Closed -$250K – 589
2022
Q4 		$250K Buy
+3,018
New +$240K 0.17% 252

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bridgefront Capital's TECH Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Bio-Techne (TECH) in Q2 2026: 15,017 shares worth $1.06M. The stake represents 0.28% of the portfolio and ranks #110 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in TECH as recently as Q2 2024.

Bridgefront Capital first reported a position in TECH in Q4 2022 and has held it in 6 quarters since. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Bridgefront Capital held 15,017 shares of Bio-Techne worth $1.06M as of Q2 2026.
  • Bio-Techne was a new Bridgefront Capital position in Q2 2026.
  • Bio-Techne made up 0.28% of Bridgefront Capital's portfolio in Q2 2026, its #110 holding.
  • Bridgefront Capital first reported a position in Bio-Techne in Q4 2022 and has held it in 6 quarters since.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.